#non-small-cell lung cancer

Finding Grace in Adversity

FDA Approves First Pre-Surgery Immunotherapy for Lung Cancer

What You Should Know About Non-Small Cell Lung Cancer

Finding Grace in Adversity

FDA Approves First Pre-Surgery Immunotherapy for Lung Cancer

What You Should Know About Non-Small Cell Lung Cancer

Pulling a Rabbit Out of a Hat: Last-Minute Access to a New Lung Cancer Drug

As blogger Dann Wonser’s treatment options dwindled, the FDA is about to approve a new med for his lung cancer.

Retevmo Slows Progression of RET-Positive Lung, Medullary Thyroid Cancers

Two new clinical trials compare Retevmo (selpercatinib) with other standard treatments for tumors with changes in the RET gene.

Lung Cancer Treatment Research Enters a New Era

Better outcomes were achieved with combinations of experimental new drugs targeting common and rare tumour mutations.

FDA Approves Augtyro for ROS1-Positive Non-Small-Cell Lung Cancer

Repotrectinib led to tumor shrinkage in 79% of patients who had not previously used a tyrosine kinase inhibitor.

CAR-T therapy in which modified T cells (illustrated in white) attack cancer

Immunotherapy Before and After Surgery Improves Lung Cancer Outcomes

Adding checkpoint inhibitors to chemotherapy before surgery and continuing them alone afterward reduces the risk of recurrence and death.

American Cancer Society Expands Lung Cancer Screening Recommendation

Annual screening is now recommended for current and former smokers ages 50 to 80, regardless of whether they quit.

MUST read

Teresa (right) and her sister Joyce (left)

When the Caregiver Becomes the Patient: Teresa’s Lung Cancer Story [SPONSORED]

A Better Treatment Approach for “Atypical” Lung Cancers

My Life Stopped the Second I Got This Diagnosis

Alecensa Delays Recurrence of Early-Stage Lung Cancer

People who received the targeted therapy after surgery were less likely to experience recurrence or brain metastasis.

FDA Approves Keytruda Immunotherapy for Operable Lung Cancer

The checkpoint inhibitor is now indicated for pre- and post-surgery treatment of Stage II or III non-small-cell lung cancer.

Lung, Kidney and Neuroendocrine Tumor Cancer Studies Led by Dana-Farber Presented at ESMO Congress

Other studies focused on bladder cancer, prostate cancer and liquid biopsies.

When Your Latest Cancer Test Results Are Not What You Expected

“I’ve gotten pretty good at bouncing back,” writes Dann Wonser after getting kicked out of a cancer clinical trial and facing chemo.

Duration of Lung Cancer Immunotherapy

Immune checkpoint inhibitors have revolutionized lung cancer treatment, but the optimal duration of therapy is unknown.

Electrical Therapy Shows Promise for Lung Cancer but Fails for Ovarian Cancer

Tumor-treating fields therapy uses electricity delivered via a wearable device to kill cancer cells.

Lung Cancer Trial of Tagrisso Draws Praise—and Some Criticism

Osimertinib led to a 51% improvement in survival, but some say the placebo group did not receive adequate treatment.

Immunotherapy Before and After Surgery Shows Benefit for Lung Cancer Patients

New results from the AEGEAN clinical trial offer good news to people with non-small cell lung cancer.

How Long Do Lung Cancer Patients Need to Stay on Immunotherapy?

Responders may be able to discontinue immune checkpoint inhibitors after two years with no decrease in survival.

Cancer Immunotherapy Is Safe and Effective for People With HIV

HIV-positive people who use checkpoint inhibitors have side effects, response rates and survival comparable to those of HIV-negative people.

#non-small-cell lung cancer

Finding Grace in Adversity

FDA Approves First Pre-Surgery Immunotherapy for Lung Cancer

What You Should Know About Non-Small Cell Lung Cancer

Finding Grace in Adversity

FDA Approves First Pre-Surgery Immunotherapy for Lung Cancer

What You Should Know About Non-Small Cell Lung Cancer

Pulling a Rabbit Out of a Hat: Last-Minute Access to a New Lung Cancer Drug

Retevmo Slows Progression of RET-Positive Lung, Medullary Thyroid Cancers

Lung Cancer Treatment Research Enters a New Era

FDA Approves Augtyro for ROS1-Positive Non-Small-Cell Lung Cancer

Immunotherapy Before and After Surgery Improves Lung Cancer Outcomes

American Cancer Society Expands Lung Cancer Screening Recommendation

MUST read

When the Caregiver Becomes the Patient: Teresa’s Lung Cancer Story [SPONSORED]

A Better Treatment Approach for “Atypical” Lung Cancers

My Life Stopped the Second I Got This Diagnosis

Alecensa Delays Recurrence of Early-Stage Lung Cancer

FDA Approves Keytruda Immunotherapy for Operable Lung Cancer

Lung, Kidney and Neuroendocrine Tumor Cancer Studies Led by Dana-Farber Presented at ESMO Congress

When Your Latest Cancer Test Results Are Not What You Expected

Duration of Lung Cancer Immunotherapy

Electrical Therapy Shows Promise for Lung Cancer but Fails for Ovarian Cancer

Lung Cancer Trial of Tagrisso Draws Praise—and Some Criticism

Immunotherapy Before and After Surgery Shows Benefit for Lung Cancer Patients

How Long Do Lung Cancer Patients Need to Stay on Immunotherapy?

Cancer Immunotherapy Is Safe and Effective for People With HIV

Science News

Ask Cancer Health